$4.89
+0.34 (+7.47%)
Analyst Consensus
Strong Buy
14
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+268.9% upside
Low Target
$12.20
Average Target
$18.04
High Target
$27.27
Current Price
$4.89
Current
$4.89
$4.89
Target
$18.04
$18.04
$12.20
$18.04 avg
$27.27
Scenario Analysis
Bear Case
$12.20
149.5%
Low target
Base Case
$18.04
+268.9%
Avg target
Bull Case
$27.27
+457.7%
High target
Risk/Reward
3.1x
Highly favorable
Price in Context
52-Week High
$16.45
-70.3% from high
52-Week Low
$4.11
+19.0% from low
Target vs 52W High
$18.04
+9.7% vs high
Next Earnings Report
Nov 10, 2026 · Before Market Open
2d
until earnings
EPS Est: $-1.03
Earnings in 2 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 82% | $257.58 | -11.6% |
| AMGN | Hold | 42 | 43% | $190.87 | -58.5% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +117.3% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -19.9% |
| MRNA | Hold | 31 | 35% | $149.45 | -41.2% |
| REGN | Buy | 37 | 70% | $76.80 | -91.5% |
| NTRA | Strong Buy | 30 | 90% | $142.91 | -54.0% |
| RVMD | Strong Buy | 29 | 93% | $114.11 | -40.7% |